Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease

By Ryu J.K.   Kim S.U.   McLarnon J.G.  

Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. : 700-704

Elsevier

Access to resources Recommend Favorite

Neuroprotective Effect of a CNTF-Expressing Lentiviral Vector in the Quinolinic Acid Rat Model of Huntington's Disease

By de Almeida L.P.   Zala D.   Aebischer P.   Déglon N.  

Neurobiology of Disease, Vol. 8, Iss. 3, 2001-06 ,pp. : 433-446

Academic Press

Access to resources Recommend Favorite

Maintenance of Susceptibility to Neurodegeneration Following Intrastriatal Injections of Quinolinic Acid in a New Transgenic Mouse Model of Huntington's Disease

By Petersen A.   Chase K.   Puschban Z.   DiFiglia M.   Brundin P.   Aronin N.  

Experimental Neurology, Vol. 175, Iss. 1, 2002-05 ,pp. : 297-300

Elsevier

Access to resources Recommend Favorite

The IGF-I Amino-Terminal Tripeptide Glycine-Proline-Glutamate (GPE) Is Neuroprotective to Striatum in the Quinolinic Acid Lesion Animal Model of Huntington's Disease

By Alexi T.   Hughes P.E.   van Roon-Mom W.M.C.   Faull R.L.M.   Williams C.E.   Clark R.G.   Gluckman P.D.  

Experimental Neurology, Vol. 159, Iss. 1, 1999-09 ,pp. : 84-97

Elsevier

Access to resources Recommend Favorite

Metabolic Alterations in the Prefrontal and Cingulate Cortices are Related to Behavioral Deficits in a Rodent Model of Attention-deficit Hyperactivity Disorder

By Barbelivien A.   Ruotsalainen S.   Sirviö J.  

Cerebral Cortex, Vol. 11, Iss. 11, 2001-11 ,pp. : 1056-1063

Oxford University Press

Access to resources Recommend Favorite